TABLE 1.
Correlation of RealTime HCV with bDNA assay and CAP/CTM for determination of HCV RNA concentrations in patients infected with genotypes 1 to 5
| Genotype | No. of samples | Mean (range) concna (log10 IU/ml) by RealTime HCV | bDNA assay
|
CAP/CTM
|
||
|---|---|---|---|---|---|---|
| Mean (range) concn (log10 IU/ml) | Difference in concn (log10 IU/ml) from that by RealTime HCV | Mean (range) concn (log10 IU/ml) | Difference in concn (log10 IU/ml) from that by RealTime HCV | |||
| 1 | 30 | 5.50 (4.0-6.7) | 5.48 (4.1-6.6) | −0.02 | 6.22 (5.4-7.2) | 0.72 |
| 2 | 12 | 5.96 (5.1-6.8) | 5.74 (4.9-6.4) | −0.22 | 5.99 (5.1-6.8) | 0.03 |
| 3 | 16 | 5.58 (4.4-6.7) | 5.31 (4.3-6.5) | −0.27 | 5.36 (3.8-6.4) | −0.22 |
| 4 | 4 | 5.41 (4.9-5.6) | 5.22 (4.6-5.5) | −0.19 | 4.14 (3.9-4.6) | −1.27 |
| 5 | 3 | 5.36 (4.1-6.7) | 5.33 (4.0-6.6) | −0.03 | 5.45 (3.9-6.9) | 0.09 |
a
Mean (range) concentration, mean (range) HCV RNA concentration.